Risk factors identification of COVID‐19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab‐Pakistan
Immunity Inflammation and Disease,
Год журнала:
2023,
Номер
11(8)
Опубликована: Авг. 1, 2023
Abstract
Background
Accessibility
to
the
immense
collection
of
studies
on
noncommunicable
diseases
related
coronavirus
disease
2019
(COVID‐19)
and
severe
acute
respiratory
syndrome
2
(SARS‐CoV‐2)
is
an
immediate
focus
researchers.
However,
there
a
scarcity
information
about
chronic
obstructed
pulmonary
(COPD),
which
associated
with
high
rate
infection
in
COVID‐19
patients.
Moreover,
by
combining
effects
SARS‐CoV‐2
COPD
patients,
we
may
be
able
overcome
formidable
obstacles
factors,
diagnosis
influencers.
Materials
Methods
A
retrospective
study
280
patients
was
conducted
at
DHQ
Hospital
Muzaffargarh
Punjab,
Pakistan.
Negative
binomial
regression
describes
risk
fixed
successive
variables.
The
association
described
Cox
proportional
hazard
model
coefficient
determined
through
log‐likelihood
observation.
Patients
had
their
survival
mortality
plotted
Kaplan–Meier
curves.
Results
increased
death
due
variables
such
as
cough,
lower
tract
(LRTI),
tuberculosis
(TB),
body‐aches
being
1.369,
0.693,
0.170,
0.217
times
higher
(95%
confidence
interval
[CI]:
0.747–1.992),
CI:
0.231–1.156),
0.008–0.332),
−0.07
0.440)
while
it
decreased
0.396
normal
condition.
Conclusion
We
found
that
symptoms
(cough,
LRTI,
TB,
bodyaches)
are
statistically
significant
who
were
most
infected
SARS‐CoV‐2.
Язык: Английский
Chronic Obstructive Pulmonary Disease Patients With Community‐Acquired Pneumonia on Inhaled Corticosteroid Therapy: A Comprehensive Analysis of Risk Factors, Disease Burden, and Prevention Strategies
Health Science Reports,
Год журнала:
2025,
Номер
8(1)
Опубликована: Янв. 1, 2025
ABSTRACT
Background
Chronic
obstructive
pulmonary
disease
(COPD)
patients
commonly
exhibit
significant
morbidity
and
experience
a
diminished
quality
of
life.
Since
there
has
been
no
prior
research
on
pneumonia
in
our
study
population,
we
carried
out
this
to
learn
more
about
the
situation.
Methods
A
retrospective
analysis
912
COPD
with
CAP
who
were
receiving
ICS
treatment
at
DHQ
Hospital
Muzaffargarh,
Punjab,
Pakistan
was
conducted.
Study
began
February
2022
ended
2023.
Using
multinomial
logistic
regression,
odds
ratio
relative
risk
Kaplan–Meier
curves
showed
time‐to‐death
recovery
by
status.
Results
Patients
having
smoking
history
from
25
pack
years
above
had
22.791
higher
(95%
CI:
20.413–31.515),
21.527
HTN
12.323–57.103),
16.955
diabetes
22.954–29.331),
13.964
death
severity
without
COVID‐19
vaccination
5.988–32.561)
compared
10
15
years.
Conclusion
shorter
duration
lower
risk,
vice
versa,
while
vaccinated
less
severe
as
non‐vaccinated
patients.
Язык: Английский
The synergistic link between sonic hedgehog signaling pathway and gut–lung axis: Its influential role toward chronic obstructive pulmonary disease progression
Developmental Dynamics,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
Abstract
Sonic
Hedgehog
(SHH)
is
an
evolutionarily
conserved
signaling
pathway
essential
for
embryonic
development,
tissue
homeostasis,
and
tumorigenesis.
Aberrant
activation
of
the
SHH
induces
various
types
cancer
different
immune
dysregulation.
extremely
important
morphogen
during
lung
as
it
regulates
interaction
between
epithelial
mesenchymal
transitions
(EMT)
in
airways.
Cigarette
smoking
triggers
EMT
activates
pathway,
which
leads
to
damage
development
diseases,
such
COPD,
a
smoker's
disease.
also
directs
gut–lung
axis
(GLA)
formation
via
epithelial–mesenchymal
signaling.
The
abruption
or
alteration
GLA
responsible
COPD
pathogenesis.
In
this
review,
we
elucidate
overview
its
inhibitor
HHIP,
SHH's
prominence
dysregulation
pathogenesis
link
with
clinical
features.
We
provide
insights
into
linked
nicotine
their
influence
on
Язык: Английский
Targeting Non-Eosinophilic Immunological Pathways in COPD and AECOPD: Current Insights and Therapeutic Strategies
Dur E Maknoon Razia,
Chencheng Gao,
Chao Wang
и другие.
International Journal of COPD,
Год журнала:
2025,
Номер
Volume 20, С. 511 - 532
Опубликована: Март 1, 2025
COPD
is
a
multifactorial
illness
characterized
by
long-term
restriction
of
airflow
and
an
inflammatory
reaction
in
the
lungs.
The
associated
emphysema
leads
to
breakdown
alveolar
proteins
abnormal
expansion
lung
air
spaces.
Chronic
bronchitis
caused
same
disease
can
result
increased
deposition
structural
proteins,
narrowing
airways,
excessive
mucus
secretion
leading
acute
exacerbation
(AECOPD).
most
commonly
prescribed
medications
for
it,
such
as
glucocorticoids
bronchodilators,
provide
important
therapeutic
benefits,
but
they
also
have
negative
side
effects,
including
immunosuppression
infection.
Therefore,
it
necessary
develop
treatment
that
specifically
target
immune
system
molecular
components.
This
review
focuses
on
non-eosinophilic
aspects
immunological
modulation
management.
Since,
existing
literature
extensively
covers
eosinophilic
inflammation,
this
aims
fill
gap
examining
alternative
pathways
their
implications.
findings
suggest
targeting
specific
responses
may
enhance
efficacy
while
minimizing
adverse
effects
with
traditional
therapies.
In
summary,
emphasizes
importance
advancing
research
into
mechanisms
COPD,
prescribing
development
novel
therapies
more
effectively
manage
disease.
Язык: Английский
Urban–rural differences in pneumonia risk in patients with chronic obstructive pulmonary disease: a nationwide register-based study
European Clinical Respiratory Journal,
Год журнала:
2025,
Номер
12(1)
Опубликована: Март 13, 2025
Background
Urban–rural
differences
in
treatment
within
chronic
obstructive
pulmonary
disease
(COPD)
have
been
documented
Denmark,
and
we
aim
to
investigate
such
the
risk
of
pneumonia.
Язык: Английский
Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
European Clinical Respiratory Journal,
Год журнала:
2024,
Номер
11(1)
Опубликована: Май 29, 2024
Background
A
decreasing
use
of
inhaled
corticosteroids
(ICS)
in
patients
with
a
hospital-registered
diagnosis
chronic
obstructive
pulmonary
disease
(COPD)
has
recently
been
documented
Denmark.
ICS
treatment
is
not
recommended
high
pneumonia
risk,
and
we
aimed
to
assess
the
development
relation
occurrence.
Язык: Английский
Exploring the Future of Prompt Engineering in Healthcare: Mission and Vision, Methods, Opportunities, Challenges, Issues and Their Remedies, Contributions, Advantages, Disadvantages, Applications, and Algorithms
Chinnem Rama Mohan,
Rapelli Naga Sathvik,
Chitta Kushal
и другие.
Journal of The Institution of Engineers (India) Series B,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 8, 2024
Язык: Английский
Advancements and challenges in the management of pneumonia in elderly patients with COPD
Expert Review of Respiratory Medicine,
Год журнала:
2024,
Номер
unknown, С. 1 - 15
Опубликована: Окт. 30, 2024
Chronic
Obstructive
Pulmonary
Disease
(COPD)
significantly
predisposes
the
elderly
to
pneumonia,
presenting
a
complex
interplay
of
pulmonary
dysfunction
and
infection
risk.
Язык: Английский
Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases
Biomedicines,
Год журнала:
2024,
Номер
13(1), С. 4 - 4
Опубликована: Дек. 24, 2024
The
Special
Issue
"Molecular
Mechanisms,
Diagnoses,
and
Treatments
of
Respiratory
Diseases"
in
the
journal
Biomedicines
compiles
critical
advancements
understanding
respiratory
diseases,
focusing
on
their
molecular
mechanisms,
diagnostic
approaches,
therapeutic
strategies
[...].
Язык: Английский